APIs, Excipients, and Manufacturing eBook
Read the article:
Shining a Light on Photochemistry in Flow
Read the ebook:
Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook
Shining a Light on Photochemistry in Flow
News
Article
Pharmaceutical TechnologyPharmaceutical Technology, APIs, Excipients, and Manufacturing, October 2021
Pages: 50–57
The ever-increasing interest in photochemistry has inspired the development of innovative, modular flow photochemistry reactors.
Sergey Yarochkin/Stock.adobe.com
Advancements in technology combined with the rediscovery of new ‘reagentless’ activation methods—such as using light in photochemistry and electrons in electrochemistry—have changed the way researchers devise synthesis routes toward novel molecules and set up their experiments. Photochemistry has gained much recognition over the past 20 years, and this growing trend has led to the development of innovative, modular flow photochemistry systems that allow users to efficiently switch between chemistries.
Read this article in Pharmaceutical Technology’s October 2021 APIs, Excipients, and Manufacturing eBook.
About the author
Andrew Mansfield is flow chemistry leader at Syrris.
Article Details
Pharmaceutical Technology
eBook: APIs, Excipients, and Manufacturing, October 2021
October 2021
Pages: 50–57
Citation
When referring to this article, please cite it as A. Mansfield, “Shining a Light on Photochemistry in Flow,” Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook (October 2021).
Articles in this issue
Pharmaceutical Knowledge Management: Experiences in Drug Development and Manufacturing
Shining a Light on Photochemistry in Flow
Predicting Tablet Potency in Continuous Manufacturing
Building Robust Specifications Using Powder Testing
Global Regulatory Approach to API Manufacturing
Seeking Economies of Scale for Biocatalysis
API Development and Manufacturing: Advantages of Working with Small Molecules
Rethinking, Recalibrating, and Retooling
Recent Videos
Related Content
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024Podcast
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024Podcast
In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
